Management of bone health in adult solid organ transplant recipients: a multidisciplinary care pathway
Abstract
Bone fragility is a major cause of morbidity and reduced quality of life among adult solid organ transplant (SOT) recipients. Despite guideline recommendations, bone health screening and posttransplant treatment remain inconsistent, and optimal therapeutic strategies are not well standardized. We reviewed the relevant literature, along with professional society guidance, and integrated institutional clinical experience to develop a streamlined multidisciplinary care pathway and define key performance indicators for transplant and bone health specialist teams. All non-kidney SOT candidates should undergo spine and hip dual-energy X-ray absorptiometry (DXA) with vertebral fracture assessment at listing, whereas kidney transplant candidates should undergo DXA only when the results are expected to influence management. High-risk patients, defined by a fragility fracture or a T-score ≤-2.5, should be referred for specialist care. After transplantation, non-kidney SOT recipients should receive osteoporosis therapy within 2 to 4 months if they have not been treated in the prior year, with treatment guided by renal function and bone turnover status. Kidney transplant recipients should undergo DXA, with referral and treatment tailored to fracture risk, bone turnover, and renal function. Bone biopsy should be considered when the underlying bone disease is unclear. Early risk stratification, standardized assessment, and coordinated multidisciplinary management are essential for…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.